DoW Neurofibromatosis Synergistic Idea Award

The summary for the DoW Neurofibromatosis Synergistic Idea Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Defense Health Agency Contracting Activity - DHACA, which is the U.S. government agency offering this grant.
DoW Neurofibromatosis Synergistic Idea Award: Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Synergistic Idea Award (SIA) supports new ideas that represent synergistic approaches to neurofibromatosis (NF) research involving two or three Principal Investigators (PIs). These investigators should utilize their complementary and synergistic perspectives to address a central problem or question in NF research. Applications must include preliminary and/or published data that are relevant to NF and the proposed research project.Distinctive Features:• Partnering Principal Investigators: One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. An additional one or two PI(s) will be identified as a Partnering PI. Each partner will be recognized as a PI, submit a separate application (even if the partners are at the same organization), and receive an individual award.
Federal Grant Title: DoW Neurofibromatosis Synergistic Idea Award
Federal Agency Name: Defense Health Agency Contracting Activity - DHACA (DOD-AMRAA)
Grant Categories: Science and Technology and other Research and Development
Type of Opportunity: Discretionary
Funding Opportunity Number: HT942526NFRPSIA
Type of Funding: Grant
CFDA Numbers: 12.420
CFDA Descriptions: Information not provided
Current Application Deadline: September 22nd, 2026
Original Application Deadline: September 22nd, 2026
Posted Date: June 25th, 2026
Creation Date: June 25th, 2026
Archive Date: October 22nd, 2026
Total Program Funding: $6,400,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards: 2
Cost Sharing or Matching: No
Last Updated: June 25th, 2026
Applicants Eligible for this Grant
Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
Grant Announcement Contact
eBRAP Help Desk
Phone: 301-682-5507
Email: [email protected]
eBRAP Help Desk
Similar Government Grants
DoW Neurofibromatosis Exploration-Hypothesis Development Award
DoW Neurofibromatosis Research Academy - Scholar Award
DoW Neurofibromatosis Investigator-Initiated Research Award
DOW Combat Readiness - Medical Research Program Translational Research Award
DoW Neurofibromatosis Research Academy - Leadership Award
FY2006 Deployed War Fighter Protection Research Program
Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)C...
Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) ...
More Grants from the Defense Health Agency Contracting Activity - DHACA
DoW Neurofibromatosis Exploration-Hypothesis Development Award
DoW Neurofibromatosis Research Academy - Scholar Award
DoW Neurofibromatosis Investigator-Initiated Research Award

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2026 FederalGrants.com